Literature DB >> 25027804

The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model.

Fikret Erdemir1, Fatih Firat, Fatma Markoc, Dogan Atilgan, Bekir Suha Parlaktas, Yunus Emre Kuyucu, Yusuf Gencten.   

Abstract

INTRODUCTION: Priapism is defined as persisting (>4 h), painful and abnormal tumescence that can occur without sexual stimulation. Three subtypes priapisms are seen-the non-ischemic priapism, intermittent and the ischemic priapism. In ischemic priapism, there is an abnormality in the veno-occlusive mechanism, resulting in venous stasis and accumulation of deoxygenated blood within the penile cavernosal tissue. Cavernosal tissue necrosis develops after extended period of ischemia and is eventually replaced by fibrotic tissue. It may results in erectile dysfunction if not treated promptly. Although, standard treatment of the ischemic priapism is penile aspiration and intracavernosal alpha-adrenergic agents, new oral agents have been investigated to reduce the cavernosal damage. In this study, the effect of different doses of pentoxifylline on cavernosal tissues was evaluated.
MATERIALS AND METHODS: Thirty-six male Wistar albino rats, age 5.5-6 months and weighing 250-300 g, were used in this study. The rats were randomly divided into five groups. In Group 1 (n = 7), the control group, only penectomy was performed. In Group 2 (n = 8), after 1 h of ischemic priapism, penectomy was performed. Group 3 (n = 7) received daily a 10 mg oral pentoxifylline for 4 weeks after 1 h of ischemic priapism, group 4 (n = 7) received a daily 30 mg oral pentoxifylline for 4 weeks after 1 h of ischemic priapism, and group 5 (n = 7) received a daily 100 mg oral pentoxifylline for 4 weeks after 1 h of ischemic priapism. At the completion of a 4-week period, penile tissues were obtained. Before penile tissues were obtained, intracavernosal pressures measured with electrical field stimulation and smooth muscle collagen ratio were evaluated pathologically.
RESULTS: Electrical field stimulation-induced intracavernosal relaxation decreased in group 2 compared with group 1 (p < 0.05). Electrical field stimulation-induced relaxation enhanced in the group 3, 4 and 5 compared to group 2 (p < 0.05). In group 2, the collagen density was significantly higher than group 1. Administration of pentoxifylline reduced the collagen density caused by ischemic priapism in groups 3, 4 and 5 compared with group 2.
CONCLUSION: The results of the present study showed that ischemic priapism caused damage in the penile tissues of rats, and treatment with pentoxifylline reduced the harmful effects of ischemic priapism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027804     DOI: 10.1007/s11255-014-0769-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  40 in total

1.  Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction.

Authors:  Maarten Albersen; Thomas M Fandel; Haiyang Zhang; Lia Banie; Guiting Lin; Dirk De Ridder; Ching-Shwun Lin; Tom F Lue
Journal:  Eur Urol       Date:  2010-10-26       Impact factor: 20.096

Review 2.  Acute management of priapism in men.

Authors:  Yeng K Tay; Daniel Spernat; Kathryn Rzetelski-West; Sree Appu; Chris Love
Journal:  BJU Int       Date:  2012-04       Impact factor: 5.588

3.  Incidence of priapism in emergency departments in the United States.

Authors:  Florian Roghmann; Andreas Becker; Jesse D Sammon; Miriam Ouerghi; Maxine Sun; Shyam Sukumar; Orchidee Djahangirian; Kevin C Zorn; Khurshid R Ghani; Giorgio Gandaglia; Mani Menon; Pierre Karakiewicz; Joachim Noldus; Quoc-Dien Trinh
Journal:  J Urol       Date:  2013-04-09       Impact factor: 7.450

4.  Persistent priapism and histological modifications of the erectile tissue. Two case reports.

Authors:  Daniele Minardi; Giulio Milanese; Andrea Benedetto Galosi; Gaetano Donatelli; Giovanni Muzzonigro
Journal:  Arch Ital Urol Androl       Date:  2004-06

Review 5.  A pathophysiology-based approach to the management of early priapism.

Authors:  Jason R Kovac; Siu K Mak; Maurice M Garcia; Tom F Lue
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

6.  Pentoxifylline improves blood flow to both testes in testicular torsion.

Authors:  Cağri Savaş; Hüseyin Dindar; Tülin Aras; Selçuk Yücesan
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 7.  Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature.

Authors:  Da-Chao Zheng; Hai-Jun Yao; Ke Zhang; Ming-Xi Xu; Qi Chen; Yan-Bo Chen; Zhi-Kang Cai; Mu-Jun Lu; Zhong Wang
Journal:  Asian J Androl       Date:  2012-08-27       Impact factor: 3.285

8.  Phosphodiesterase 5 inhibition-induced coronary vasodilation is reduced after myocardial infarction.

Authors:  Daphne Merkus; Marleen Visser; Birgit Houweling; Zhichao Zhou; Jessica Nelson; Dirk J Duncker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-15       Impact factor: 4.733

9.  Ischemic glans penis after circumcision.

Authors:  Yuan-Sheng Tzeng; Shou-Hung Tang; En Meng; Teng-Fu Lin; Guang-Huan Sun
Journal:  Asian J Androl       Date:  2004-06       Impact factor: 3.285

10.  Pentoxifylline treatment improves neurological and neurochemical deficits in rats subjected to transient brain ischemia.

Authors:  Renata de Barros Bruno; Tiago Fontenele Marques; Tiago Melo Teixeira Batista; Júlio César Sá Silveira Lima; Karla Gleice de Arruda; Priscili Fortaleza Souza Fiúza Lima; Nilton da Silva Santos; Geanne M A Cunha; Helio Vitorino Nobre Vitor; Glauce Socorro de Barros Viana
Journal:  Brain Res       Date:  2009-01-07       Impact factor: 3.252

View more
  4 in total

1.  The effects of oxytocin on penile tissues in experimental priapism model in rats.

Authors:  Engin Kolukcu; Sahin Kilic; Bekir Suha Parlaktas; Fikret Erdemir; Velid Unsal; Dogan Atılgan; Nihat Uluocak
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

Review 2.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 3.  Advances in the understanding of priapism.

Authors:  Matthew Hudnall; Amanda B Reed-Maldonado; Tom F Lue
Journal:  Transl Androl Urol       Date:  2017-04

4.  Effect of lysyl oxidase (LOX) on corpus cavernous fibrosis caused by ischaemic priapism.

Authors:  Liang Gao; Changjing Wu; Fudong Fu; Xuanhe You; Xue Ma; Feng Qin; Tao Li; Run Wang; Jiuhong Yuan
Journal:  J Cell Mol Med       Date:  2017-12-26       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.